Loading people...
Charles Cycon is a Partner at Touchdown Ventures and serves as a Partner for AB Health Ventures, the corporate venture capital arm of AmerisourceBergen, based in the Greater Philadelphia Area. In his concurrent capacity as Vice President of Global Market Development at AmerisourceBergen, recently rebranded as Cencora, he directs strategic corporate venture investments across the healthcare and pharmaceutical sectors. His professional background includes previous finance and private equity roles at Susquehanna International Group, alongside operational and advisory experience with healthcare startups such as SteadyMD, Acclinate, and TrakCel. Cycon earned dual bachelor's degrees in psychology and marketing from the University of Notre Dame in 2007, followed by a master's degree in applied positive psychology from the University of Pennsylvania in 2014. His current professional focus centers on advancing digital health and pharmacy innovation through targeted corporate venture capital initiatives.
Charles Cycon holds the significant position of Partner at AmerisourceBergen, a leading global healthcare company dedicated to improving patient outcomes through its comprehensive pharmaceutical sourcing and distribution services. In this pivotal role, Charles is integral to the company's strategic growth initiatives, focusing on corporate development and identifying key investment opportunities that bolster AmerisourceBergen's market position and future trajectory.
As a Partner, Charles Cycon's responsibilities likely encompass a broad spectrum of strategic activities. He is expected to play a crucial role in evaluating potential mergers, acquisitions, and strategic partnerships that align with AmerisourceBergen's core business objectives. His investment focus areas typically include innovative healthcare technologies, digital health solutions, advancements in pharmaceutical services, and enhancements to the global supply chain. These strategic investments are vital for AmerisourceBergen to adapt to the evolving healthcare landscape, expand its service offerings, and maintain its leadership in pharmaceutical distribution and specialty solutions.
While specific details of Charles Cycon's career background are not publicly detailed, his role as a Partner at a company of AmerisourceBergen's stature suggests a robust professional history. This background likely includes extensive experience in corporate finance, strategic planning, mergers and acquisitions, or a deep understanding of the healthcare sector. Professionals in such positions often possess a strong analytical acumen, a keen eye for market trends, and a proven track record in identifying and executing complex business deals that drive significant value. His expertise would be instrumental in navigating the intricacies of the healthcare industry, assessing market dynamics, and making informed decisions that contribute to AmerisourceBergen's long-term success.
AmerisourceBergen, now operating as Cencora, consistently seeks to invest in areas that enhance its ability to deliver innovative solutions to manufacturers, providers, and pharmacies. Charles Cycon's involvement ensures that these strategic investments are carefully vetted for their potential to create synergies, improve operational efficiencies, and ultimately benefit patients worldwide. His work is critical in helping AmerisourceBergen remain at the forefront of healthcare innovation, ensuring the company continues to provide essential services and solutions in a dynamic global market.
Charles Cycon is a Partner at AmerisourceBergen, a prominent global healthcare company. He plays a key role in the company's strategic investments and corporate development initiatives.
As a Partner at AmerisourceBergen, Charles Cycon focuses on strategic investments that support the company's growth and mission. These typically include areas like healthcare technology, pharmaceutical services, supply chain innovation, and strategic partnerships within the healthcare sector.
Charles Cycon works at AmerisourceBergen, a leading global healthcare company that provides pharmaceutical sourcing and distribution services, now operating as Cencora.
